Interferon alpha plus ribavirin tor chronic hepatitis C genotype 1b non-responder patients to interferon alone.

被引：0
|
作者：
Iacono, OL
Castro, A
Diago, M
Cors, R
Borque, MJ
Buey, LG
Monzon, CG
Pedreira, J
Otero, RM
机构：
[1] Univ Autonoma Madrid, Madrid, Spain
[2] Univ Palermo, Madrid, Spain
[3] Hosp Juan Canalejo, A Coru A, Spain
[4] Gen Hosp, Valencia, Spain
[5] Hosp Princess, Madrid, Spain
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
424
引用
下载
收藏
页码：266A / 266A
页数：1
相关论文
共 50 条
  • [1] Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study
    Andreone, P
    Cursaro, C
    Gramenzi, A
    Fiorino, S
    Di Ciammarino, L
    Miniero, R
    D'Errico, A
    Grigioni, WF
    Gasbarrini, G
    Bernardi, M
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (08): : 688 - 694
  • [2] Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone
    Milella, M
    Santantonio, T
    Pietromatera, G
    Maselli, R
    Casalino, C
    Mariano, N
    Genchi, C
    Pastore, G
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (03): : 211 - 215
  • [3] Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)
    Oguz, Dilek
    Cicek, Bahattin
    Filik, Levent
    Odemis, Bulent
    Kilic, Mesut
    Altintas, Engin
    Zengin, Neslihan
    Altiparmak, Emin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (04) : 580 - 583
  • [4] Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)
    Dilek Oguz
    Bahattin Cicek
    Levent Filik
    Bulent Odemis
    Mesut Kilic
    Engin Altintas
    Neslihan Zengin
    Emin Altiparmak
    World Journal of Gastroenterology, 2005, (04) : 580 - 583
  • [5] Retreatment for chronic hepatitis C of interferon non-responder patients.: Preliminary results of a multicenter randomized controlled trial of interferon plus ribavirin versus interferon alone.
    de Lédinghen, V
    Bernard, PH
    Trimoulet, P
    Bourlière, M
    Portal, I
    Rémy, AJ
    Szostak, N
    Longo, F
    Thiefin, G
    Abergel, A
    Dumas, F
    Lucidarme, D
    Blanc, P
    Zylberberg, H
    Capron, D
    Doll, J
    Fleury, H
    Couzigou, P
    HEPATOLOGY, 1998, 28 (04) : 374A - 374A
  • [6] Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C
    Puig-Basagoiti, F
    Forns, X
    Furcic, I
    Ampurdanés, S
    Giménez-Barcons, M
    Franco, S
    Sanchez-Tapias, JM
    Saiz, JC
    JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 1067 - 1075
  • [7] Interferon plus ribavirin (6 vs 12 months) in chronic hepatitis C patients non responders to interferon alone.
    Picciotto, A
    Torre, F
    Campo, N
    Giusto, R
    Brizzolara, R
    Sinelli, N
    Giudici-Cipriani, A
    Grasso, A
    De Conca, V
    Marenco, G
    Menardo, G
    Michetti, P
    HEPATOLOGY, 1999, 30 (04) : 263A - 263A
  • [8] Ribavirin plus α-IFN in patients with chronic hepatitis C -: Genotype 1b non responder to α-IFN.
    Sicilliano, R
    Russello, M
    Rosso, D
    Rapisarda, S
    Elia, G
    Benigno, R
    Santangelo, N
    Carrà, R
    Zammataro, M
    HEPATOLOGY, 1998, 28 (04) : 715A - 715A
  • [9] Efficacy of interferon plus ribavirin in chronic hepatitis C patients non responders to interferon alone
    Picciotto, A
    Campo, N
    Torre, F
    Brizzolara, R
    Sinelli, N
    Celle, G
    HEPATOLOGY, 1998, 28 (04) : 479A - 479A
  • [10] Neutralizing antibodies to interferon alpha in a chronic hepatitis C patient non-responder to pegylated interferon
    Santantonio, Teresa
    Milella, Michele
    Antonelli, Guido
    Scagnolari, Carolina
    JOURNAL OF HEPATOLOGY, 2006, 45 (05) : 759 - 761
12345